Press Releases
MED-EL Acquires Two Gene Therapy Programs Targeting Genetic Causes of Balance and Hearing Disorders
Strategic acquisition from Rescue Hearing Inc. expands and complements MED-EL comprehensive portfolio of inner ear
Strategic acquisition from Rescue Hearing Inc. expands and complements MED-EL comprehensive portfolio of inner ear
May 19, 2022 – Rescue Hearing Inc. (RHI), a leader in innovative gene therapies for hearing loss, is thrilled to announce a strategic partnership with Myrtelle, a leading innovator in gene therapy solutions.
December 8th, 2021 – Rescue Hearing Inc. (RHI), a leader in innovative gene therapies for hearing loss, is proud to announce the appointment of Dr. Athanasia Warnecke, MD, PhD, to its Scientific Advisory Board. A renowned physician-scientist and senior researcher at Hannover Medical School, Dr. Warnecke brings unparalleled expertise in inner ear regeneration, neuroprotection, and translational therapies to accelerate RHI’s mission of delivering curative treatments.
June 1st, 2021 – Rescue Hearing Inc. (RHI) has reached an exciting milestone in the fight against genetic hearing loss. Our latest research has unveiled a novel gene therapy technique designed to restore hearing in individuals affected by STRC gene mutations, a common cause of hereditary hearing impairment.
February 11th, 2021 – Rescue Hearing Inc. (RHI), a team of visionary physicians, scientists, and bioengineers focused on developing new gene therapies to eliminate hearing loss, today announced significant research findings in the treatment of genetic hearing loss using AAV-mediated gene therapy.
October 13th, 2020 – Rescue Hearing Inc. (RHI), a team of visionary, internationally recognized physicians, scientists, and bioengineers focused on developing new gene therapies to eliminate hearing loss, announced the addition of Business Advisor Andrew Koopman.
September 24th, 2020 – Rescue Hearing Inc. (RHI), a team of visionary, internationally recognized physicians, scientists, and bioengineers focused on developing new gene therapies to eliminate hearing loss, announced the addition of Drug Development Advisor Dr. Lee Golden.
March 12th, 2020 – Rescue Hearing Inc. (RHI), a team of visionary, internationally recognized physicians, scientists, and bioengineers focused on developing new gene therapies to eliminate hearing loss, announced the signing of Dr. Jeffrey Holt to its Scientific Advisory Board today.
June 7th, 2016 – Rescue Hearing Inc. (RHI), a leader in innovative gene therapies for hearing loss, is proud to announce the appointment of Dr. Hinrich Staecker, MD, PhD, to its Scientific Advisory Board. A distinguished leader in otology, neurotology, and hearing restoration research at the University of Kansas Medical Center, Dr. Staecker brings extensive expertise in gene therapy, inner ear drug delivery, and regenerative medicine to advance RHI’s mission of delivering curative treatments.
PRESS RELEASE • MAY 2026
MED-EL has acquired full rights to Rescue Hearing’s MYO7A and STRC gene therapy programs, expanding research into gene-based therapeutic approaches targeting genetic causes of hearing and balance disorders.